Seminars in Oncology
Volume 34, Issue 2 , Pages 165-172, April 2007

Immunotherapeutic Strategies for High-Risk Bladder Cancer

  • Padmanee Sharma

      Affiliations

    • Department of Genitourinary Medical Oncology and Immunology, The University of Texas M.D. Anderson Cancer Center, Houston, TX.
    • Corresponding Author InformationAddress correspondence to Padmanee Sharma, MD, PhD, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1374, Houston, TX 77030.
    • ,
  • Lloyd J. Old

      Affiliations

    • Ludwig Institute for Cancer Research, New York Branch at Memorial Sloan-Kettering Cancer Center, New York, NY.
    • ,
  • James P. Allison

      Affiliations

    • Howard Hughes Medical Institute and Department of Immunology, Memorial Sloan-Kettering Cancer Center, New York, NY.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported in part by the UTMDACC Bladder Cancer SPORE Career Development Award 5P50 CA091846 04 (PP-CDP4), Physician Scientist Program Award and Institutional Research Grant (P. Sharma).

PII: S0093-7754(06)00481-7

doi:10.1053/j.seminoncol.2006.12.004

Seminars in Oncology
Volume 34, Issue 2 , Pages 165-172, April 2007

Article Tools

* Image Usage & Resolution